- 產(chǎn)品描述
OPI違禁品質(zhì)控操作說明書
廣州健侖生物科技?有限公司
本司長期供應(yīng)尼古?。商鎸帲z測試劑盒,其主要品牌包括美國NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品,國產(chǎn)產(chǎn)品,試劑盒的實驗方法是膠體金方法。
【什么是質(zhì)控品】
1. 質(zhì)控品的來源:
質(zhì)控品的來源同校準(zhǔn)品大致相同,廠商可能會更具自己的要求添加了很多物質(zhì),此時有些物質(zhì)的添加量常常達(dá)到病理狀態(tài)的高濃度,在應(yīng)用于某一項目時,對這個項目來說基質(zhì)效應(yīng)將更大。
2. 定值方法:
有些廠商會給自己的標(biāo)準(zhǔn)品定一個定值范圍,這個定值范圍是由廠商聯(lián)合幾家使用同樣檢測系統(tǒng)的臨床用戶,僅多次測定得出的均值。此時如果將該質(zhì)控品應(yīng)用于另一個檢測系統(tǒng),由于方法學(xué)的不同,可能得出同廠商給出值有較大差異的值。此時不能認(rèn)為該檢測系統(tǒng)的準(zhǔn)確度不佳。此時需要強調(diào)的是檢測系統(tǒng)都是用來測定新鮮血清的,不是用來測定質(zhì)控品或其他物質(zhì)的。檢測系統(tǒng)只有在檢測新鮮血清是得出的結(jié)果才具有溯源性。不同檢測系統(tǒng)之間只有在檢測新鮮血清時才具可比性。
我司還提供其它進(jìn)口或國產(chǎn)試劑盒:登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。
OPI違禁品質(zhì)控操作說明書
歡迎咨詢
歡迎咨詢
以下是出售的一小部分產(chǎn)品
名稱 | 英文名 | 尿檢為陽性的時間段(用藥后),僅供參考 | 備注 |
MOP | Morphine, the main component of heroin | 2小時-4天 | A variety of drugs can be detected in time will be positive individual differences, the metabolic rate and detection results and taking individual, route of Administration (suction, oral, injection) and each dosage has a great relationship. In general, the metabolism of injection speed, quickly urine can be positive, other treatment methods is relatively slow. A large amount of urine test lasted for a long time |
MAMP | Morphine / methamphetamine | 1小時-3天 | |
MDMA | Two, two methoxy amphetamine, commonly known as "ecstasy"" | 1小時-5小時 | |
KET | Ketamine (k) | 2小時-4小時 | |
AMP | Amphetamine, also called benzene acetone | 2小時-1天 | |
COC | Cocaine, also called cocaine | 4小時-1天 | |
BZO | Benzene, two nitrogen Zhuo (diazepam, three Lun Lun, etc.) | 2小時-3天 | |
THC | hemp | 2小時-56小時 | |
BAR | Barbiturates | 4小時-4天 | |
MTD | Methadone | 2小時-2天 | |
PCP | Benzene ring piperidine, commonly known as "angel powder. | 2小時-12小時 | |
TCA | Tricyclic antidepressants | 4小時-5天 | |
BUP | Buprenorphine | 1小時-5天 |
二維碼掃一掃
【公司名稱】 廣州健侖生物科技有限公司
【】 楊永漢
【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號二期2幢101-3室
【企業(yè)文化宣傳】
Miller 和 Good 通過在哺乳類動物體內(nèi)進(jìn)行早期胸腺摘除,導(dǎo)致細(xì)胞免疫缺陷和抗體產(chǎn)生嚴(yán)重下降,證明了存在于胸腺的免疫細(xì)胞主要執(zhí)行細(xì)胞免疫,稱之為 T 細(xì)胞。 年 Claman 和 Mitchell 等提出了 T 細(xì)胞亞群的概念。此后,人們進(jìn)一步證實了經(jīng)胸腺和法氏囊分化、成熟的 T 、 B 淋巴細(xì)胞在外周淋巴組織的分布,以及 T 、 B 細(xì)胞在抗體產(chǎn)生中的協(xié)同作用,從而建立了免疫系統(tǒng)的組織學(xué)和細(xì)胞學(xué)基礎(chǔ)。二、抗體結(jié)構(gòu)與功能的研究 世紀(jì) 年代, orter 用木瓜蛋白酶水解抗體,獲得了抗體活性片段(Fab)和可結(jié)晶片段(Fc)。用化學(xué)還原法證明抗體是由多肽鏈組成,并以抗原分析法證明了抗體分子的不均一性。此后,人們統(tǒng)一了抗體球蛋白名稱,并建立了免疫球蛋白的分類。三、免疫網(wǎng)絡(luò)學(xué)說的提出 年, Jerne 提出免疫網(wǎng)絡(luò)學(xué)說。該學(xué)說認(rèn)為:抗體和淋巴細(xì)胞表面的抗原受體存在*性,在抗原進(jìn)入前,抗體處于相對穩(wěn)定狀態(tài),當(dāng)抗原進(jìn)入機體后,使這種平衡被打破,導(dǎo)致特異性抗體產(chǎn)生,當(dāng)后者達(dá)到一定量時,可引起抗*型抗體產(chǎn)生。由此可見,在同一機體內(nèi)一組抗體的*型正常紅細(xì)胞電鏡圖正常紅細(xì)胞電鏡圖決定基可被另一組抗*型抗體分子識別;而一組淋巴細(xì)胞表面的抗原受體可被另一組淋巴細(xì)胞表面抗*型表面受體所識別,這樣在淋巴細(xì)胞和抗體之間就形成了*型 - 抗*型免疫網(wǎng)絡(luò)。網(wǎng)絡(luò)學(xué)說探討了免疫調(diào)節(jié)機制,提出由抗原刺激引起的免疫應(yīng)答不是無休止地進(jìn)行,而是受*型抗體的制約,籍以維持機體的生理穩(wěn)定和平衡。
Miller and Good carried out early thymus removal in mammals, resulting in a serious reduction in cellular immune deficiencies and antibody production, demonstrating that immune cells present in the thymus mainly perform cellular immunity, called T cells. Claman and Mitchell et al. proposed the concept of T cell subpopulations. Since then, it has been further confirmed that the distribution of mature and mature T and B lymphocytes in the peripheral lymphoid tissue through the thymus and bursa, and the synergistic effect of T and B cells in antibody production, thus establishing the histological and immunological system. Basics of cytology. Second, the structure and function of antibodies research Century, the era of papain hydrolysis of antibodies, obtained antibody active fragments (Fab) and crystallizable fragments (Fc). The chemical reduction method was used to prove that the antibody consisted of polypeptide chains and the heterogeneity of the antibody molecule was demonstrated by antigen analysis. Since then, people have unified the names of antibody globulin and established the classification of immunoglobulins. III. The Opinion of Immune Network Theory In the year, Jerne proposed the theory of immune network. The theory is that the antigen receptors on the surface of antibodies and lymphocytes are unique. Before the antigen enters, the antibody is in a relatively stable state. When the antigen enters the body, the balance is broken, resulting in the production of specific antibodies. When a certain amount is reached, anti-idiotype antibodies can be produced. From this it can be seen that the unique erythrocyte electron micrograph of a group of antibodies in the same body can be recognized by another group of anti-idiotypic antibody molecules; the antigen receptors on the surface of one group of lymphocytes can be used by another. The lymphocyte surface is recognized by anti-idiotypic surface receptors so that an idiotype-anti-idiotypic immune network is formed between the lymphocytes and the antibody. The theory of cyberlogy discusses the mechanism of immune regulation and suggests that the immune response caused by antigen stimulation is not endless, but is restricted by idiotype antibodies to maintain the body's physiological stability and balance.